Assetmark Inc. grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 31.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 135,108 shares of the medical research company’s stock after purchasing an additional 32,547 shares during the period. Assetmark Inc.’s holdings in Agilent Technologies were worth $18,150,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently made changes to their positions in the business. Farther Finance Advisors LLC lifted its stake in Agilent Technologies by 11.9% during the third quarter. Farther Finance Advisors LLC now owns 1,944 shares of the medical research company’s stock valued at $288,000 after buying an additional 207 shares in the last quarter. Impax Asset Management Group plc lifted its stake in Agilent Technologies by 8.2% during the third quarter. Impax Asset Management Group plc now owns 2,667,616 shares of the medical research company’s stock valued at $396,088,000 after buying an additional 203,234 shares in the last quarter. Catalina Capital Group LLC purchased a new stake in Agilent Technologies during the third quarter valued at about $220,000. Maia Wealth LLC purchased a new stake in Agilent Technologies during the third quarter valued at about $173,000. Finally, M&G PLC lifted its stake in Agilent Technologies by 0.4% during the third quarter. M&G PLC now owns 274,738 shares of the medical research company’s stock valued at $40,661,000 after buying an additional 973 shares in the last quarter.
Wall Street Analyst Weigh In
A has been the subject of a number of research analyst reports. JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their price target for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Bank of America reduced their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. Robert W. Baird reduced their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research report on Thursday, February 27th. Finally, Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and an average price target of $146.15.
Agilent Technologies Price Performance
Shares of A opened at $126.62 on Friday. The firm has a market cap of $36.10 billion, a PE ratio of 29.11, a PEG ratio of 3.45 and a beta of 1.11. The firm’s 50 day moving average price is $139.85 and its 200 day moving average price is $138.79. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. Agilent Technologies, Inc. has a twelve month low of $121.45 and a twelve month high of $155.35.
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The company had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.
Agilent Technologies Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.78%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.76%.
Insider Buying and Selling at Agilent Technologies
In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
- Five stocks we like better than Agilent Technologies
- Insider Trades May Not Tell You What You Think
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- Investing in Travel Stocks Benefits
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- What to Know About Investing in Penny Stocks
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.